From the Institute of Medicine Evaluating Postmarketing Drug SafetyByDavid S. MacDougallJune 3rd 2007
AHA Discourages Cox-2 Inhibitor use for Patients With CV Risk FactorsByDavid S. MacDougallMay 31st 2007